Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Emerging Markets Earnings Roundup: Abbott Laboratories, Novartis (Part 1)

This article was originally published in PharmAsia News

Executive Summary

Abbott and Novartis talk at length in quarterly earning calls on emerging markets as key to the fortunes of both companies. China again dominated the subject, but chief executives at both firms say the rapid pace of change in the country’s health sector remains a singular opportunity that means the only option is to double down on efforts to overcome regulatory and other hurdles.

Advertisement

Related Content

A Year After Chinese Health Authorities Vow To Rid Country Of Deliberately Adulterated Milk, A New Melamine Scandal Surfaces

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC084916

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel